Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2018 Feb 9;16(6):862–869.e3. doi: 10.1016/j.cgh.2018.01.052

Figure 1. Flow chart of eligible subjects and classification of appropriateness of surveillance.

Figure 1

Appropriateness based on the interval between 2nd and 3rd EGD. Over-surveillance defined as < 3 year, under-surveillance as > 5 years, and never surveilled as no 2nd EGD.